top of page
wave.jpg

WHERE DIGITAL INNOVATION ENSURES MATERNAL DRUG SAFETY 

VISION

Changing the way the world thinks about testing drugs for maternal safety

Reproductive toxicology testing for novel substances should be reproducible, efficient, accurate and secure.  It should be nonbinary and allow artificial intelligence enhanced pattern recognition, predict drug interactions, and differentiate spontaneous mutations from those caused by chemical exposure.

Pills

THE DIFFERENCE

PATENTED
METHOD

Innovation behind four worldwide patents empower the digital techniques for evaluating the maternal safety profiles of drugs and chemicals. The TIO process produces quantitative data at near micron level, allowing pattern prediction and better evaluation of drug interactions.  The cloud-based platform protects and stores your companies’ critical data in a secure and cost-effective manner.

Data on a Touch Pad

WHY USE TIO

DECREASED LIABILITY EXPOSURE

Better data and better analytic tools protect from future liability. Predictive analytics suggest efficient testing for critical interactions between compounds.  Owning secure data allows look back studies to update safety sheets and defend future liability claims.

Tio transparent black logo.PNG

The Numbers

3

COMPANIES

18K

AVAILABLE MARKET DRUGS

4

PATENTS

1.6M

PATIENTS IN NEED

Image by Christopher Burns

WHAT WE OFFER

A different approach using a revolutionary

method of testing

We are a motivated team of scientists, engineers, and medical professionals with decades of experience in toxicology, pharmacology, and data software design.  

bottom of page